The Novo Nordisk study POSEIDON – including 18,904 patients across 18 countries - showed that cardiovascular (CV) inflammation remai...

              With a mean weight loss of 16.6%[1], Wegovy®️ pill demonstrates best-in-class weight-loss efficacy and is the first oral G...